LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

Search

Globus Medical Inc (Class A)

Geschlossen

Branche Gesundheitswesen

74.97 1.68

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

74.7

Max

75.28

Schlüsselkennzahlen

By Trading Economics

Einkommen

39M

32M

Verkäufe

23M

630M

KGV

Branchendurchschnitt

126.83

104.138

EPS

0.75

Gewinnspanne

5.044

Angestellte

5,000

EBITDA

43M

128M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+6.28 upside

Dividenden

By Dow Jones

Nächstes Ergebnis

5. Nov. 2024

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

56M

10B

Vorheriger Eröffnungskurs

73.29

Vorheriger Schlusskurs

74.97

Nachrichtenstimmung

By Acuity

50%

50%

167 / 389 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

Globus Medical Inc (Class A) Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

1. Nov. 2024, 22:50 UTC

Heiße Aktien

Stocks to Watch: Nvidia, Intel, Sherwin-Williams, Dow, Nuwellis

1. Nov. 2024, 22:43 UTC

Wichtige Markttreiber

Nvidia, Sherwin-Williams Shares Up on Addition to DJIA

1. Nov. 2024, 22:13 UTC

Wichtige Markttreiber

Chewy Up 5% on S&P MidCap 400 Inclusion

1. Nov. 2024, 21:39 UTC

Ergebnisse

Insurance Company Chubb Projects Up to $300 Million Pre-Tax Loss on Hurricane

2. Nov. 2024, 13:53 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- Update

2. Nov. 2024, 13:44 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2. Nov. 2024, 13:00 UTC

Ergebnisse

China's EV Makers Set Sights on Latin America in Global Expansion -- WSJ

2. Nov. 2024, 12:58 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2. Nov. 2024, 12:48 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- WSJ

2. Nov. 2024, 12:32 UTC

Ergebnisse

Berkshire Profits Fell 6% in Third Quarter. The Buybacks Are on Pause. -- Barrons.com

2. Nov. 2024, 12:28 UTC

Akquisitionen, Fusionen, Übernahmen

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2. Nov. 2024, 12:17 UTC

Ergebnisse

Berkshire Profits Fell 6% in Third Quarter. The Buybacks Are on Pause. -- Barrons.com

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q EPS $18272.00 >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q BNSF Operating Earnings $1.38B >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Berkshire Hathaway Energy Company Operating Earnings $1.63B >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Insurance-Underwriting Operating Earnings $750M >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Other Operating Loss $877M >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Insurance-Investment Income Operating Earnings $3.66B >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Net $26.25B >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Other Controlled Businesses Operating Earnings $3.34B >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Non-Controlled Businesses Operating Earnings $199M >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Operating Earnings $10.09B >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Investment, Derivative Gains $16.16B >BRKA

2. Nov. 2024, 09:30 UTC

Top News

Awful Jobs Report Aside, the Economy Is Still Strong -- Heard on the Street -- WSJ

2. Nov. 2024, 08:20 UTC

Market Talk
Ergebnisse

Tech, Media & Telecom Roundup: Market Talk

2. Nov. 2024, 08:20 UTC

Market Talk
Ergebnisse

Auto & Transport Roundup: Market Talk

1. Nov. 2024, 22:51 UTC

Ergebnisse

Correction to Nvidia to Replace Intel in Dow Jones Industrial Average Article -- WSJ

1. Nov. 2024, 22:00 UTC

Top News
Ergebnisse

Nvidia to Replace Intel in Dow Jones Industrial Average. Sherwin-Williams Also Joins. -- WSJ

1. Nov. 2024, 21:29 UTC

Top News
Ergebnisse

Exxon and Chevron Feel Brunt of Cheaper Oil -- 2nd Update

1. Nov. 2024, 21:24 UTC

Ergebnisse

Insurance Company Chubb Projects Up to $300M Pre-Tax Loss on Hurricane

Peer-Vergleich

Kursveränderung

Globus Medical Inc (Class A) Prognose

Kursziel

By TipRanks

6.28% Vorteil

12-Monats-Prognose

Durchschnitt 79.58 USD  6.28%

Hoch 100 USD

Tief 55 USD

Basierend auf 15 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Globus Medical Inc (Class A) – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

15 ratings

9

Buy

5

Halten

1

Sell

Technischer Score

By Trading Central

73.49 / 75.07Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Weak Bearish Evidence

Langfristig

Weak Bullish Evidence

Stimmung

By Acuity

167 / 389 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

EBITDA

Betriebsergebnis

$

Über Globus Medical Inc (Class A)

Globus Medical, Inc. is a medical device company. The Company is primarily focused on implants that promote healing in patients with musculoskeletal disorders. The Company group its products into two categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in an expansive range of spinal, orthopedic and neurosurgical procedures. Its Enabling Technologies are comprised of imaging, navigation and robotics (INR) solutions for assisted surgery, which are computer-assisted intelligent systems designed to improve a surgeon’s capabilities, and ultimately improve patient care and reduce radiation exposure for all involved. Its INR solutions include the ExcelsiusGPS platform, which is a robotic guidance and navigation system that supports minimally invasive and open procedures with screw and interbody spacer placement applications.